Results 231 to 240 of about 58,087 (312)

[131I]Iodometomidate for Targeted Radionuclide Therapy of Advanced Adrenocortical Carcinoma

, 2011
Stefanie Hahner, Michael C. Kreißl, Martin Faßnacht, Heribert Haenscheid, Pascal Knoedler, Katharina Lang, Andreas K. Buck, Christoph Reiners, Bruno Allolio, Andreas Schirbel   +9 more
openalex   +1 more source

Somatostatin-receptor-targeted radionuclide therapy for progressive meningioma: benefit linked to⁶⁸Ga-DOTATATE/-TOC uptake [PDF]

, 2016
Katharina Seystahl, Veit M. Stoecklein, Ulrich Schüller, Elisabeth J. Rushing, Guillaume Nicolas, Niklaus Schäfer, Harun Ilhan, Athina Pangalu, Michael Weller, Jörg‐Christian Tonn, Michael Sommerauer, Nathalie L. Albert   +11 more
openalex   +1 more source

Retraction: Efficacy and Safety of Peptide Receptor Radionuclide Therapy for the Treatment of Pancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis of Comparative Studies. [PDF]

Cureus
Zhao J, Pei X, Li Y.
europepmc   +1 more source

Investigating the significance of SPECT/CT-SUV for monitoring ¹⁷⁷Lu-PSMA-targeted radionuclide therapy: a systematic review. [PDF]

BMC Med Imaging
Alkahtani TO.
europepmc   +1 more source

Targeted radionuclide therapy in endocrine-related cancers: advances in the last decade. [PDF]

Front Endocrinol (Lausanne), 2023
Al-Toubah T, Strosberg J, Hallanger-Johnson J, El-Haddad G.   +3 more
europepmc   +1 more source

Targeted Radionuclide Therapy: An Evolution Toward Precision Cancer Treatment [PDF]

, 2017
Hossein Jadvar
openalex   +1 more source

Mathematical Modeling Unveils Optimization Strategies for Targeted Radionuclide Therapy of Blood Cancers. [PDF]

Cancer Res Commun
Kuznetsov M, Adhikarla V, Caserta E, Wang X, Shively JE, Pichiorri F, Rockne RC.   +6 more
europepmc   +1 more source

Optimization Processes of Clinical Chelation-Based Radiopharmaceuticals for Pathway-Directed Targeted Radionuclide Therapy in Oncology. [PDF]

Pharmaceutics
Tomiyoshi K, Wilson LJ, Mourtada F, Mourtada JS, Namiki Y, Kamata W, Yang DJ, Inoue T.   +7 more
europepmc   +1 more source

Current status of peptide receptor radionuclide therapy in grade 1 and 2 gastroenteropancreatic neuroendocrine tumours. [PDF]

J Neuroendocrinol
Kuiper J, Zoetelief E, Brabander T, de Herder WW, Hofland J.   +4 more
europepmc   +1 more source

Targeted radionuclide therapy for head and neck squamous cell carcinoma: a review. [PDF]

Front Oncol
Sanwick AM, Chaple IF.
europepmc   +1 more source